Banyan Capital Management Inc. grew its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 7.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 127,912 shares of the company's stock after purchasing an additional 8,872 shares during the quarter. Henry Schein comprises approximately 4.8% of Banyan Capital Management Inc.'s investment portfolio, making the stock its 12th biggest holding. Banyan Capital Management Inc. owned about 0.11% of Henry Schein worth $9,344,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Alliancebernstein L.P. grew its stake in Henry Schein by 21.9% during the 1st quarter. Alliancebernstein L.P. now owns 218,340 shares of the company's stock worth $14,954,000 after buying an additional 39,188 shares during the last quarter. Farther Finance Advisors LLC grew its stake in shares of Henry Schein by 237.3% during the first quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company's stock worth $186,000 after acquiring an additional 1,898 shares during the last quarter. Great Lakes Advisors LLC purchased a new stake in shares of Henry Schein during the first quarter worth about $4,477,000. State of Alaska Department of Revenue increased its holdings in shares of Henry Schein by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock valued at $1,000,000 after acquiring an additional 395 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. raised its position in shares of Henry Schein by 5.2% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock valued at $941,000 after purchasing an additional 678 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have weighed in on the stock. Stifel Nicolaus reissued a "hold" rating and set a $75.00 target price (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Baird R W downgraded Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Robert W. Baird restated a "neutral" rating and issued a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. JPMorgan Chase & Co. dropped their price target on Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. Finally, UBS Group reduced their price objective on Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research note on Wednesday, August 6th. Five equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $76.67.
Get Our Latest Analysis on HSIC
Henry Schein Trading Up 1.9%
Shares of HSIC stock opened at $69.21 on Wednesday. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49. The company has a market cap of $8.39 billion, a price-to-earnings ratio of 22.33, a PEG ratio of 2.24 and a beta of 0.86. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The stock has a 50 day simple moving average of $68.67 and a 200-day simple moving average of $69.28.
Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.Henry Schein's revenue was up 3.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.
Henry Schein Profile
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.